DRY POWDER FORMULATIONS ADMINISTERED BY THE INHALATION ROUTE COMPRISING A COMBINATION OF TIOTROPIUM BROMIDE, SALMETEROL XYNAFOATE AND FLUTICASONE PROPIONATE.

摘要

A pharmaceutical composition comprising tiotropium bromide, salmeterol xynafoate and fluticasone propionate, and its use in the symptomatic and/or prophylactic treatment of respiratory diseases especially asthma, allergic rhinitis, chronic obstructive pulmonary disease (COPD).